StockData

RxSight, Inc. (RXST) stock

RXSTNasdaqOphthalmic GoodsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 10/3074% below fair value
$5.38+0.10 (+1.89%)

Close on Nov 12, 2026Market cap $223.77MP/E –Yield –

RxSight gross margin

Gross margin is gross profit as a percentage of revenue.

RxSight's gross margin for the twelve months ending Jun 30, 2026 was 77.5%. For fiscal 2025 it was 76.6%, against 70.7% the year before. The highest annual figure on record is 76.6% in fiscal 2025.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202576.6%+5.9
FY2024Dec 31, 202470.7%+10.4
FY2023Dec 31, 202360.4%+16.8
FY2022Dec 31, 202243.5%+23.5
FY2021Dec 31, 202120.0%+8.4
FY2020Dec 31, 202011.6%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 202676.7%+1.8
Q1 FY2026Mar 31, 202676.1%+1.3
Q4 FY2025Dec 31, 202577.5%+5.9
Q3 FY2025Sep 30, 202579.9%+8.4
Q2 FY2025Jun 30, 202574.9%+5.4
Q1 FY2025Mar 31, 202574.8%+4.7
Q4 FY2024Dec 31, 202471.6%+9.8
Q3 FY2024Sep 30, 202471.4%+9.6
Q2 FY2024Jun 30, 202469.5%+11.8
Q1 FY2024Mar 31, 202470.1%+10.8
Q4 FY2023Dec 31, 202361.8%+15.6
Q3 FY2023Sep 30, 202361.9%+19.4
Q2 FY2023Jun 30, 202357.7%+15.6
Q1 FY2023Mar 31, 202359.3%+17.2
Q4 FY2022Dec 31, 202246.1%+12.1
Q3 FY2022Sep 30, 202242.5%+19.3
Q2 FY2022Jun 30, 202242.1%+58.7
Q1 FY2022Mar 31, 202242.1%+9.9
Q4 FY2021Dec 31, 202134.0%+6.0
Q3 FY2021Sep 30, 202123.2%+5.9
Q2 FY2021Jun 30, 2021-16.6%+0.9
Q1 FY2021Mar 31, 202132.1%–
Q4 FY2020Dec 31, 202028.1%–
Q3 FY2020Sep 30, 202017.3%–
Q2 FY2020Jun 30, 2020-17.5%–

More RxSight figures

See a number that looks wrong?